MDMA therapy tested to heal COVID frontline trauma
NCT ID NCT05455996
Summary
This study is testing whether MDMA-assisted therapy can safely reduce symptoms of post-traumatic stress in healthcare workers who experienced trauma during COVID-19 frontline work. It will involve 30 participants who live near New York City and will receive therapy sessions combined with MDMA in a controlled setting. Researchers will measure changes in PTSD symptoms to see if this approach provides lasting relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
InnerMost, PBC
New York, New York, 10010, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Memoru
Boulder, Colorado, 80302, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.